In this study, we sought to identify genetic vulnerabilities in CUX1-deficient AML cells using CRISPR/Cas9 screening to assess whether CUX1 deficiency invokes adaptive cellular pathways critical for leukemia survival. The gene discussed is CUX1; the disease is leukemia.